|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,190.30 INR | -3.16% |
|
-0.67% | +7.62% |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan -- Update | DJ |
| 22/07 | Shares in Generic-Drug Makers Fall After Trump's Tariff Plan | DJ |
| Market Cap | 64TCr 666.35Cr 585.52Cr 546.54Cr 501.58Cr 938.92Cr 962.07Cr 6.48TCr 2.53TCr 32TCr 2.5TCr 2.45TCr 1,09200Cr | P/E 2026 |
44.2x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 60TCr 625.32Cr 549.47Cr 512.89Cr 470.7Cr 881.12Cr 902.84Cr 6.08TCr 2.38TCr 30TCr 2.35TCr 2.3TCr 1,02500Cr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.61x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -3.16% | ||
| 1 week | -0.67% | ||
| Current month | -0.64% | ||
| 1 month | -0.64% | ||
| 3 months | -8.98% | ||
| 6 months | +8.65% | ||
| Current year | +7.62% |
| 1 week | 2,178.2 |  | 2,270.2 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.16% | -0.67% | +1.70% | +178.01% | 666.35Cr | |
| +0.56% | +2.41% | +15.42% | +75.01% | 4.98TCr | |
| -1.74% | +3.57% | +56.23% | +116.36% | 3.69TCr | |
| -0.54% | +5.27% | -5.96% | +24.80% | 1.24TCr | |
| -0.68% | +0.12% | +12.05% | +76.37% | 1.17TCr | |
| +1.14% | +0.96% | +31.25% | +132.30% | 904.48Cr | |
| -1.36% | +2.46% | +47.46% | -5.54% | 714.53Cr | |
| +0.26% | +1.20% | +14.35% | +32.77% | 669.7Cr | |
| +0.61% | -3.87% | -35.09% | -1.66% | 544.65Cr | |
| +1.17% | -0.10% | +22.71% | +102.47% | 442.85Cr | |
| Average | -0.32% | +1.06% | +16.01% | +73.09% | 1.5TCr | |
| Weighted average by Cap. | -0.38% | +2.38% | +23.61% | +81.45% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 159.85Cr 140.46Cr 131.11Cr 120.33Cr 225.24Cr 230.79Cr 1.55TCr 608.01Cr 7.58TCr 600.16Cr 587.14Cr 26TCr | 17TCr 174.06Cr 152.94Cr 142.76Cr 131.02Cr 245.26Cr 251.3Cr 1.69TCr 662.04Cr 8.25TCr 653.5Cr 639.31Cr 29TCr |
| Net income | 2.05TCr 21Cr 19Cr 18Cr 16Cr 30Cr 31Cr 208.48Cr 82Cr 1.02TCr 80Cr 79Cr 3.51TCr | 2.33TCr 24Cr 21Cr 20Cr 18Cr 34Cr 35Cr 236.41Cr 92Cr 1.15TCr 91Cr 89Cr 3.98TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -34Cr -31Cr -58Cr -59Cr -399Cr -156.04Cr -1.94TCr -154.02Cr -150.68Cr -6.72TCr | -3.71TCr -39Cr -34Cr -32Cr -29Cr -55Cr -56Cr -376.94Cr -147.41Cr -1.84TCr -145.51Cr -142.35Cr -6.35TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | ₹2,190.30 | -3.16% | 4,51,791 |
| 29/26/29 | ₹2,261.70 | +3.53% | 5,93,720 |
| 28/26/28 | ₹2,184.60 | -0.52% | 4,90,034 |
| 27/26/27 | ₹2,196.00 | +0.18% | 5,93,586 |
| 24/26/24 | ₹2,192.00 | -0.59% | 4,29,562 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
